FDA.reportPublic FDA data

sohonos 1.5 MG Oral Capsule

RxCUI
2663970
RxNorm name
sohonos 1.5 MG Oral Capsule
Display name
sohonos 1.5 MG Oral Capsule
Full name
sohonos 1.5 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SOHONOSPALOVAROTENEIpsen Biopharmaceuticals, Inc.67dce406-7cc4-4d66-92de-ad18b6df06252025-03-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2663970

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
67dce406-7cc4-4d66-92de-ad18b6df0625sohonos 1.5 MG Oral Capsule [PSN] · palovarotene 1.5 MG Oral Capsule [Sohonos] [SBD] · Sohonos 1.5 MG Oral Capsule [SY]32These highlights do not include all the information needed to use SOHONOS ® safely and effectively. See full prescribing information for SOHONOS. SOHONOS (palovarotene) capsules, for oral use Initial U.S. Approval: 202320250318